M85.012
Fibrous dysplasia (monostotic), left shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibrous dysplasia is a bone disorder where normal bone is replaced with fibrous (scar-like) tissue. When confined to a single bone, it is termed monostotic fibrous dysplasia. Specifically, M85.012 refers to cases where this condition affects the left shoulder. Although it can involve any bone, the shoulder's anatomy makes it a common site for localized fibrous growths. This condition generally develops during childhood or adolescence and can influence bone strength and appearance. Many individuals with monostotic fibrous dysplasia are asymptomatic, but some may experience pain, swelling, or deformity. Understanding its causes, symptoms, and management strategies can help in making informed health decisions.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting osteoblast development and bone formation processes Spontaneous mutations in the GNAS gene during early embryonic development No clear environmental or lifestyle factors are associated with this condition
Key Symptoms: Pain in the affected shoulder, especially with activity or pressure Swelling or palpable bump over the shoulder Deformity or unevenness of the shoulder contour Limited range of motion or discomfort during movement Potential weakening of the shoulder bone, increasing fracture risk Sometimes asymptomatic, discovered incidentally on imaging
Diagnostic & Treatment
Diagnosis Path: The diagnosis of monostotic fibrous dysplasia typically involves a combination of clinical evaluation and imaging studies. An orthopedic specialist may order X-rays, which often reveal characteristic bone changes: a well-defined, expanded lesion with a homogeneous, ground-glass appearance. MRI scans can further delineate the extent of tissue involvement and soft tissue relationships. In some cases, a biopsy may be performed to confirm the diagnosis, where a small tissue sample from the lesion is examined microscopically, revealing fibrous tissue replacing normal bone tissue. Blood tests are generally not diagnostic but may be used to rule out other metabolic causes.
Treatment Protocols: Management of fibrous dysplasia generally depends on symptoms, lesion size, and risk of fracture or deformity. Treatment options include: - Observation: In cases where the lesion is asymptomatic and stable, regular monitoring may be recommended. - Medications: Bisphosphonates might be used to decrease bone pain and reduce lesion activity, although their use remains under study. - Surgical intervention: When deformity, significant pain, or fracture risk is present, procedures such as deformity correction, curettage with bone grafting, or internal fixation may be undertaken. - Physical therapy: To maintain shoulder function and strength. It is essential to have a tailored treatment plan developed by a healthcare provider experienced in bone disorders. Regular follow-up is vital to monitor for changes in the condition and to manage any complications early.
Clinical Advice & FAQs
Billing Guidance
Is M85.012 a billable ICD-10 code?
Yes, M85.012 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M85.012?
Clinical documentation must specify the nature of Fibrous dysplasia (monostotic), left shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference